|
|
|
This bibliography is provided as a service to our readers. It is compiled from the entries in the BCERF Environmental Risk Factors Bibliographic Database.
(1998). Essiac for cancer? Treatmentupdate 10, 4-5.
(2000). Black Cohosh: The Woman's Herb? In Harvard Women's Health Watch, 7, 6.
(2003). Most alternative therapies not so hot for hot flashes. In Harvard Women's Health Watch, 10, 3.
Abebe, W. (2002). Herbal medication: potential for adverse interactions with analgesic drugs. Journal of Clinical Pharmacy and Therapeutics 27, 391-401.
Abourashed, E. A., El-Alfy, A. T., Khan, I. A., and Walker, L. (2003). Ephedra in perspective--a current review. Phytotherapy Research 17, 703-712.
Adlercreutz, H. (2002). Phytoestrogens and breast cancer. Journal of Steroid Biochemistry and Molecular Biology 83, 113-118.
Arab, L. (2000). Epidemiologic challenges in the study of the efficacy and safety of medicinal herbs. Public Health Nutr 3, 453-457.
Baber, N. (2003). Complementary medicines, clinical pharmacology and therapeutics. British Journal of Clinical Pharmacology 55, 225.
Barnes, J., Phillipson, J. D., Anderson, L. A., and Newall, C. A. (2002a). Herbal Medicines: A Guide for Health Care Professionals, 1st edn, Pharmaceutical Press).
Barnes, J., Phillipson, J. D., Anderson, L. A., and Newall, C. A. (2002b). Potential drug-herb interactions. In Herbal Medicines:A guide for healthcare professionals (Pharmaceutical Press), pp. 497-501.
Barnes, J. (2003a). Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety. British Journal of Clinical Pharmacology 55, 331-340.
Barnes, S. (2003b). Phyto-oestrogens and osteoporosis: what is a safe dose? British Journal of Nutrition 89, S101-108.
Bendich, A. (2000). The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. Journal of the American College of Nutrition 19, 3-12.
Berger, L. (2003). Herbs for Hot Flashes: New Attention, Mixed Results. In New York Times (NY).
Blumenthal, M., Busse, W. R., Goldberg, A., Gruenwald, J., Hall, T., Riggins, C. W., and Rister, R. S. (1998). The Complete German Comission E Monographs: Therapeutic Guide to Herbal Medicines, 1st edn (USA, American Botanical Council).
Blumenthal, M., Goldberg, A., and Brinckmann, J. (2000). Herbal Medicine - Expanded Comission E Monographs, 1st edn (USA, Integrative Botanical Council).
Briggs, D. R. (2002). The regulation of herbal medicines in Australia. Toxicology 181-182, 565-570.
Cartwright, M. (2001). Herbal use during pregnancy and lactation. The Digest, American Dietetic Association, Summer 1-5.
Cassidy, A. (2003). Potential risks and benefits of phytoestrogen-rich diets. International Journal for Vitamin and Nutrition Research 73, 120-126.
CDC (2002). Hepatic Toxicity Possibly Associated with Kava-Containing Products -- United States, Germany, and Switzerland, 1999-2002.
Chang, J. (2000). Medicinal herbs: drugs or dietary supplements? Biochemical Pharmacology 59, 211-219.
Choi, S. W. (1999). Vitamin B12 deficiency: a new risk factor for breast cancer? Nutrition Reviews 57, 250-253.
Conaway, C. C., Yang, Y. M., and Chung, F. L. (2002). Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 3, 233-255.
Council, N. R. (2004). Dietary Supplements: A Framework for Evaluating Safety (Washington, DC, The National Academies Press).
Currie, B. J., and Clough, A. R. (2003). Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use? Medical Journal of Australia 178, 421-422.
De Smet, P. A. (2002). Herbal remedies. New England Journal of Medicine 347, 2046-2056.
De Smet, P. A. G. M. (1991). Toxicological outlook on the quality assurance of herbal remedies. In Adverse Effects of Herbal Drugs, P. A. G. M. De Smet, K. Keller, R. Hansel, and R. F. SChandler, eds. (Berlin, Springer-Verlag), pp. 1-72.
FDA (2002). Kava-containing dietary supplements may be associated with severe liver injury.
Fugh-Berman, A., and Ernst, E. (2001). Herb-drug interactions: review and assessment of report reliability. British Journal of Clinical Pharmacology 52, 587-595.
Fugh-Berman, A., and Kronenberg, F. (2001). Red clover (Trifolium pratense) for menopausal women: current state of knowledge. Menopause 8, 333-337.
Fugh-Berman, A. (2003). "Bust enhancing" herbal products. Obstetrics and Gynecology 101, 1345-1349.
Fugh-Berman, A., and Kronenberg, F. (2003). Complementary and alternative medicine (CAM) in reproductive-age women: a review of randomized controlled trials. Reproductive Toxicology 17, 137-152.
Gardiner, P. (2000). Chasteberry (Vitex agnus castus) (Longwood Herbal Task Force (http://www.mcp.edu/herbal/vitex/vitex.pdf)), pp. 1-14.
Goldman, P. (2001). Herbal medicines today and the roots of modern pharmacology. Annals of Internal Medicine 135, 594-600.
Greenwald, P., Milner, J. A., Anderson, D. E., and McDonald, S. S. (2002). Micronutrients in cancer chemoprevention. Cancer and Metastasis Reviews 21, 217-230.
Halliwell, B. (2000). The antioxidant paradox. Lancet 355, 1179-1180.
Hardy, M. L. (2000). Herbs of special interest to women. Journal of the American Pharmaceutical Association 40, 234-242; quiz 327-239.
Harrison, P. (1998). Herbal medicine takes root in Germany. CMAJ 158, 637-639.
Horner, N. K., and Lampe, J. W. (2000). Potential mechanisms of diet therapy for fibrocystic breast conditions show inadequate evidence of effectiveness. Journal of the American Dietetic Association 100, 1368-1380.
Hosein, S. (1998). Essiac for cancer? Treatmentupdate 10, 4-5.
Humfrey, C. D. (1998). Phytoestrogens and human health effects: weighing up the current evidence. Natural Toxins 6, 51-59.
Hunter, C. P. (2000). Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer 88, 1193-1202.
Jeri, A. R. (2002). The use of an isoflavone supplement torelieve hot flushes. Female Patient 27, 35-37.
Johanning, G. L., Heimburger, D. C., and Piyathilake, C. J. (2002). DNA methylation and diet in cancer. Journal of Nutrition 132, 3814S-3818S.
Kang, H. J., Ansbacher, R., and Hammoud, M. M. (2002). Use of alternative and complementary medicine in menopause. International Journal of Gynaecology and Obstetrics 79, 195-207.
Kaptchuk, T. J. (2002). The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Annals of Internal Medicine 136, 817-825.
Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., and Mitchell, A. A. (2002). Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287, 337-344.
Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A., Malone, W. A., Boone, C. W., Kopelovich, L., Hawk, E. T., Lieberman, R., Lawrence, J. A., et al. (2000). Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. Journal of Nutrition 130, 467S-471S.
Kenner, D., and Requena, Y. (1996). Botanical Medicine: A European Professional Perspective, 1st edn (Brookline, MA, Paradigm Publications).
Kessler, D. A. (2000). Cancer and herbs. New England Journal of Medicine 342, 1742-1743.
Khan, H. N., and Blamey, R. W. (2003). Endocrine treatment of physiological gynaecomastia. BMJ 327, 301-302.
Kiely, M., Faughnan, M., Wahala, K., Brants, H., and Mulligan, A. (2003). Phyto-oestrogen levels in foods: the design and construction of the VENUS database. British Journal of Nutrition 89, S19-23.
Klepser, T. B., and Klepser, M. E. (1999). Unsafe and potentially safe herbal therapies. American Journal of Health-System Pharmacy 56, 125-138; quiz 139-141.
Krishnan, K., Campbell, S., Abdel-Rahman, F., Whaley, S., and Stone, W. L. (2003). Cancer chemoprevention drug targets. Curr Drug Targets 4, 45-54.
Kronenberg, F., and Fugh-Berman, A. (2002). Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Annals of Internal Medicine 137, 805-813.
Kushi, L., and Giovannucci, E. (2002). Dietary fat and cancer. American Journal of Medicine 113, 63S-70S.
Larsen, T. M., Toubro, S., and Astrup, A. (2003). Efficacy and safety of dietary supplements containing conjugated linoleic acid (CLA) for the treatment of obesity-evidence from animal and human studies. Journal of Lipid Research 16, 16.
Lipkin, M., and Newmark, H. L. (1999). Vitamin D, calcium and prevention of breast cancer: a review. Journal of the American College of Nutrition 18, 392S-397S.
Lippman, S. M., and Lotan, R. (2000). Advances in the development of retinoids as chemopreventive agents. Journal of Nutrition 130, 479S-482S.
Loprinzi, C. L., Barton, D. L., and Rhodes, D. (2001). Management of hot flashes in breast-cancer survivors. Lancet Oncol 2, 199-204.
Lord, G. M., Tagore, R., Cook, T., Gower, P., and Pusey, C. D. (1999). Nephropathy caused by Chinese herbs in the UK. Lancet 354, 481-482.
Mahady, G. B., Fabricant, D., Chadwick, L. R., and Dietz, B. (2002). Black cohosh: an alternative therapy for menopause? Nutrition and Clinical Care 5, 283-289.
Mahady, G. B. (2003). Is black cohosh estrogenic? Nutrition Reviews 61, 183-186.
Mantle, D., Lennard, T. W., and Pickering, A. T. (2000). Therapeutic applications of medicinal plants in the treatment of breast cancer: a review of their pharmacology, efficacy and tolerability. Adverse Drug Reactions and Toxicological Reviews 19, 223-240.
Marasco, L. (2003). Clinical Application for Insufficient Milk Supply, pp. 1-4.
Marcus, D. M., and Grollman, A. P. (2002). Botanical medicines--the need for new regulations. New England Journal of Medicine 347, 2073-2076.
Martin, K. J., Jordan, T. R., Vassar, A. D., and White, D. B. (2002). Herbal and nonherbal alternative medicine use in Northwest Ohio. Annals of Pharmacotherapy 36, 1862-1869.
Mason, R. (2001). Alternative and Complementary Resources on Breast Cancer. Alternative & Complementary Therapies 7, 55-56.
Matthews, H. B., Lucier, G. W., and Fisher, K. D. (1999). Medicinal herbs in the United States: research needs. Environmental Health Perspectives 107, 773-778.
Miller, L. G., and Murray, W. J. (1998). Herbal Medicinals: A Clinician's Guide, 1st edn (Binghamton, NY, Pharmaceuticals Products Press).
Moulds, R. F., and Malani, J. (2003). Kava: herbal panacea or liver poison? Medical Journal of Australia 178, 451-453.
Moyad, M. A. (2002). Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women. Urology 59, 20-33.
Munoz, S. E., Piegari, M., Guzman, C. A., and Eynard, A. R. (1999). Differential effects of dietary Oenothera, Zizyphus mistol, and corn oils, and essential fatty acid deficiency on the progression of a murine mammary gland adenocarcinoma. Nutrition 15, 208-212.
Nathanson, K. L., Wooster, R., Weber, B. L., and Nathanson, K. N. (2001). Breast cancer genetics: what we know and what we need. Nature Medicine 7, 552-556.
Neuhouser, M. L. (2003). Dietary supplement use by American women: challenges in assessing patterns of use, motives and costs. Journal of Nutrition 133, 1992S-1996S.
Newman, L. A., Mason, J., Cote, D., Vin, Y., Carolin, K., Bouwman, D., and Colditz, G. A. (2002). African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer 94, 2844-2854.
Nortier, J. L., and Vanherweghem, J. L. (2002). Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). Toxicology 181-182, 577-580.
Philp, H. A. (2003). Hot flashes - a review of the literature on alternative and complementary treatment approaches. Alternative Medicine Review 8, 284-302.
Richter, R. K. (2003). Herbal Medicine: Chaos in the Marketplace (New York, The Haworth Herbal Press).
Roemheld-Hamm, B., and Dahl, N. V. (2002). Herbs, menopause, and dialysis. Seminars in Dialysis 15, 53-59.
Rose, R. C. (1998). Vitamin supplementation and breast cancer: is homeostasis a factor? Medical Hypotheses 51, 239-242.
Ruffin, M. T. t., and Rock, C. L. (2001). Do antioxidants still have a role in the prevention of human cancer? Currert Oncology Reports 3, 306-313.
Schaffer, D. M., Gordon, N. P., Jensen, C. D., and Avins, A. L. (2003). Nonvitamin, nonmineral supplement use over a 12-month period by adult members of a large health maintenance organization. Journal of the American Dietetic Association 103, 1500-1505.
Schulz, V., Rudolf, H., and Tyler, V. E. (1997a). Medicinal Plants, Phytomedicines, and Phytotherapy. In Rational Phytotherapy: A Physicians' Guide to Herbal Medicine (Springer-Verlag New York, Incorporated), pp. 1-39.
Schulz, V., Rudolf, H., and Tyler, V. E. (1997b). Rational Phytotherapy: A Physicians' Guide to Herbal Medicine, 3rd edn, Springer-Verlag New York, Incorporated).
Shanafelt, T. D., Barton, D. L., Adjei, A. A., and Loprinzi, C. L. (2002). Pathophysiology and treatment of hot flashes. Mayo Clinic Proceedings 77, 1207-1218.
Sheehan, D. M. (1998). Herbal medicines, phytoestrogens and toxicity: risk:benefit considerations. Proceedings of the Society for Experimental Biology and Medicine 217, 379-385.
Silano, M., De Vincenzi, M., De Vincenzi, A., and Silano, V. (2004). The new European legislation on traditional herbal medicines: main features and perspectives. Fitoterapia 75, 107-116.
Singh, R. H. (2002). An assessment of the ayurvedic concept of cancer and a new paradigm of anticancer treatment in Ayurveda. Journal of Alternative and Complementary Medicine 8, 609-614.
Snowden, H. M., Renfrew, M. J., and Woolridge, M. W. (2001). Treatments for breast engorgement during lactation. Cochrane Database Syst Rev, CD000046.
Steinhoff, B. (2003). Traditional herbal medicinal products: an update. Phytomedicine 10, 624.
Stephenson, J. (2003). FDA orders estrogen safety warnings: agency offers guidance for HRT use. JAMA 289, 537-538.
Stoll, B. A. (1998). Essential fatty acids, insulin resistance, and breast cancer risk. Nutrition and Cancer 31, 72-77.
Straus, S. E. (2002). Herbal medicines--what's in the bottle? New England Journal of Medicine 347, 1997-1998.
Tagliaferri, M., Cohen, I., and Tripathy, D. (2001). Complementary and alternative medicine in early-stage breast cancer. Seminars in Oncology 28, 121-134.
Talalay, P. (2001). The importance of using scientific principles in the development of medicinal agents from plants. Academic Medicine 76, 238-247.
Temple, N. J., and Kaiser Gladwin, K. (2003). Fruit, vegetables, and the prevention of cancer. Research challenges. Nutrition 19, 467-470.
Tesch, B. J. (2002). Herbs commonly used by women: an evidence-based review. Disease-a-Month 48, 671-696.
Toniolo, P., Van Kappel, A. L., Akhmedkhanov, A., Ferrari, P., Kato, I., Shore, R. E., and Riboli, E. (2001). Serum carotenoids and breast cancer. American Journal of Epidemiology 153, 1142-1147.
Trock, B. J. (1996). Breast cancer in African American women: epidemiology and tumor biology. Breast Cancer Research and Treatment 40, 11-24.
Tulchinsky, T., and Varavikova, E. (2000). The New Public Health: An Introduction for the 21st Century, 1st edn (San Diego, CA London, UK, Academic Press).
Tyler, V. E. (2000). Herbal medicine: from the past to the future. Public Health Nutr 3, 447-452.
Wade, C., Kronenberg, F., Kelly, A., and Murphy, P. A. (1999). Hormone-modulating herbs: implications for women's health. J Am Med Womens Assoc 54, 181-183.
Wagner, H. (1999). Phytomedicine research in Germany. Environmental Health Perspectives 107, 779-781.
Walsh, N. (2003). Kava banned in the U.K. due to hepatoxicity (OB/GYN News).
Wang, Z. Y., and Nixon, D. W. (2001). Licorice and cancer. Nutrition and Cancer 39, 1-11.
Wargovich, M. J., Woods, C., Hollis, D. M., and Zander, M. E. (2001). Herbals, cancer prevention and health. Journal of Nutrition 131, 3034S-3036S.
Weiger, W. A., Smith, M., Boon, H., Richardson, M. A., Kaptchuk, T. J., and Eisenberg, D. M. (2002). Advising patients who seek complementary and alternative medical therapies for cancer. Annals of Internal Medicine 137, 889-903.
Weiss, R. F. (1991). Herbal Medicine, 6th edn (Stuttgart, Germany, Hippokrates Verlag).
Whiting, P. W., Clouston, A., and Kerlin, P. (2002). Black cohosh and other herbal remedies associated with acute hepatitis. Medical Journal of Australia 177, 440-443.
Whitton, P. A., Lau, A., Salisbury, A., Whitehouse, J., and Evans, C. S. (2003). Kava lactones and the kava-kava controversy. Phytochemistry 64, 673-679.
Willett, W. (2003). Lessons from dietary studies in Adventists and questions for the future. American Journal of Clinical Nutrition 78, 539S-543S.
Willhite, L. A., and O'Connell, M. B. (2001). Urogenital atrophy: prevention and treatment. Pharmacotherapy 21, 464-480.
Williamson, E. M. (2001). Synergy and other interactions in phytomedicines. Phytomedicine 8, 401-409.
Woolf, A. D. (2003). Herbal remedies and children: do they work? Are they harmful? Pediatrics 112, 240-246.
Wuttke, W., Jarry, H., Westphalen, S., Christoffel, V., and Seidlova-Wuttke, D. (2002). Phytoestrogens for hormone replacement therapy? Journal of Steroid Biochemistry and Molecular Biology 83, 133-147.
Zhou, S., Koh, H. L., Gao, Y., Gong, Z. Y., and Lee, E. J. (2004). Herbal bioactivation: the good, the bad and the ugly. Life Sciences 74, 935-968.
Albertazzi, P., Pansini, F., Bonaccorsi, G., Zanotti, L., Forini, E., and De Aloysio, D. (1998). The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology 91, 6-11.
Atmaca, M., Kumru, S., and Tezcan, E. (2003). Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol 18, 191-195.
Augustin, L. S., Dal Maso, L., La Vecchia, C., Parpinel, M., Negri, E., Vaccarella, S., Kendall, C. W., Jenkins, D. J., and Francesch, S. (2001). Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Annals of Oncology 12, 1533-1538.
Baber, R. J., Templeman, C., Morton, T., Kelly, G. E., and West, L. (1999). Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 2, 85-92.
Baird, D. D., Umbach, D. M., Lansdell, L., Hughes, C. L., Setchell, K. D., Weinberg, C. R., Haney, A. F., Wilcox, A. J., and McLachlan, J. A. (1995). Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. Journal of Clinical Endocrinology and Metabolism 80, 1685-1690.
Balk, J. L., Whiteside, D. A., Naus, G., DeFerrari, E., and Roberts, J. M. (2002). A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. Journal of the Society for Gynecologic Investigation 9, 238-242.
Barton, D. L., Loprinzi, C. L., Quella, S. K., Sloan, J. A., Veeder, M. H., Egner, J. R., Fidler, P., Stella, P. J., Swan, D. K., Vaught, N. L., and Novotny, P. (1998). Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. Journal of Clinical Oncology 16, 495-500.
Bent, S., Tiedt, T. N., Odden, M. C., and Shlipak, M. G. (2003a). The relative safety of ephedra compared with other herbal products. Annals Internal Medicine 138, 468-471.
Bent, S., Tiedt, T. N., Odden, M. C., and Shlipak, M. G. (2003b). The relative safety of ephedra compared with other herbal products. Annals of Internal Medicine 138, 468-471.
Berger, D., Schaffner, W., Schrader, E., Meier, B., Brattstrom, A., and . (2000). Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Archives of Gynecology and Obstetrics 264, 150-153.
Budeiri, D., Li Wan Po, A., and Dornan, J. C. (1996). Is evening primrose oil of value in the treatment of premenstrual syndrome? Controlled Clinical Trials 17, 60-68.
Burke, G. L., Legault, C., Anthony, M., Bland, D. R., Morgan, T. M., Naughton, M. J., Leggett, K., Washburn, S. A., and Vitolins, M. Z. (2003). Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Menopause 10, 147-153.
Cagnacci, A., Arangino, S., Renzi, A., Zanni, A. L., Malmusi, S., and Volpe, A. (2003). Kava-Kava administration reduces anxiety in perimenopausal women. Maturitas 44, 103-109.
Chenoy, R., Hussain, S., Tayob, Y., O'Brien, P. M., Moss, M. Y., and Morse, P. F. (1994). Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 308, 501-503.
Collins, A., Cerin, A., Coleman, G., and Landgren, B. M. (1993). Essential fatty acids in the treatment of premenstrual syndrome. Obstetrics and Gynecology 81, 93-98.
Dalais, F. S., Rice, G. E., Wahlqvist, M. L., Grehan, M., Murkies, A. L., Medley, G., Ayton, R., and Strauss, B. J. (1998). Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1, 124-129.
Davis, S. R., Briganti, E. M., Chen, R. Q., Dalais, F. S., Bailey, M., and Burger, H. G. (2001). The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial. Medical Journal of Australia 174, 68-71.
De Leo, V., la Marca, A., Morgante, G., Lanzetta, D., Florio, P., and Petraglia, F. (2001). Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety. Maturitas 39, 185-188.
Ernst, E. (2002). The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Annals of Internal Medicine 136, 42-53.
Faure, E. D., Chantre, P., and Mares, P. (2002). Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 9, 329-334.
Forshee, R. A., Storey, M. L., and Ritenbaugh, C. (2003). Breast cancer risk and lifestyle differences among premenopausal and postmenopausal African-American women and white women. Cancer 97, 280-288.
Frazier, A. L., Ryan, C. T., Rockett, H., Willett, W. C., and Colditz, G. A. (2003). Adolescent diet and risk of breast cancer. Breast Cancer Res 5, R59-64.
Gandini, S., Merzenich, H., Robertson, C., and Boyle, P. (2000). Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. European Journal of Cancer 36, 636-646.
Ghadirian, P., Maisonneuve, P., Perret, C., Kennedy, G., Boyle, P., Krewski, D., and Lacroix, A. (2000). A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detection and Prevention 24, 305-313.
Girman, A., Lee, R., and Kligler, B. (2003). An integrative medicine approach to premenstrual syndrome. American Journal of Obstetrics and Gynecology 188, S56-65.
Halaska, M., Raus, K., Beles, P., Martan, A., and Paithner, K. G. (1998). [Treatment of cyclical mastodynia using an extract of Vitex agnus castus: results of a double-blind comparison with a placebo]. Ceska Gynekologie 63, 388-392.
Hale, G. E., Hughes, C. L., Robboy, S. J., Agarwal, S. K., and Bievre, M. (2001). A double-blind randomized study on the effects of red clover isoflavones on the endometrium. Menopause 8, 338-346.
Han, K. K., Soares, J. M., Jr., Haidar, M. A., de Lima, G. R., and Baracat, E. C. (2002). Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology 99, 389-394.
Hargreaves, D. F., Potten, C. S., Harding, C., Shaw, L. E., Morton, M. S., Roberts, S. A., Howell, A., and Bundred, N. J. (1999). Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clinical Endocrinol Metab 84, 4017-4024.
Hernandez Munoz, G., and Pluchino, S. (2003). Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas 44, S59-65.
Hirata, J. D., Swiersz, L. M., Zell, B., Small, R., and Ettinger, B. (1997). Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertility and Sterility 68, 981-986.
Hirose, K., Takezaki, T., Hamajima, N., Miura, S., and Tajima, K. (2003). Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women. International Journal of Cancer 107, 276-282.
Hulten, K., Van Kappel, A. L., Winkvist, A., Kaaks, R., Hallmans, G., Lenner, P., and Riboli, E. (2001). Carotenoids, alpha-tocopherols, and retinol in plasma and breast cancer risk in northern Sweden. Cancer Causes and Control 12, 529-537.
Huntley, A. L., and Ernst, E. (2003). A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 10, 465-476.
Jacobson, J. S., Troxel, A. B., Evans, J., Klaus, L., Vahdat, L., Kinne, D., Lo, K. M., Moore, A., Rosenman, P. J., Kaufman, E. L., et al. (2001). Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. Journal of Clinical Oncology 19, 2739-2745.
Jakes, R. W., Duffy, S. W., Ng, F. C., Gao, F., Ng, E. H., Seow, A., Lee, H. P., and Yu, M. C. (2002). Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiology, Biomarkers and Prevention 11, 608-613.
Khoo, S. K., Munro, C., and Battistutta, D. (1990). Evening primrose oil and treatment of premenstrual syndrome. Medical Journal of Australia 153, 189-192.
Knight, D. C., Howes, J. B., and Eden, J. A. (1999). The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 2, 79-84.
Komesaroff, P. A., Black, C. V., Cable, V., and Sudhir, K. (2001). Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 4, 144-150.
Kotani, N., Oyama, T., Sakai, I., Hashimoto, H., Muraoka, M., Ogawa, Y., and Matsuki, A. (1997). Analgesic effect of a herbal medicine for treatment of primary dysmenorrhea--a double-blind study. American Journal of Chinese Medicine 25, 205-212.
Kotsopoulos, D., Dalais, F. S., Liang, Y. L., McGrath, B. P., and Teede, H. J. (2000). The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 3, 161-167.
La Vecchia, C., Altieri, A., and Tavani, A. (2001). Vegetables, fruit, antioxidants and cancer: a review of Italian studies. European Journal of Nutrition 40, 261-267.
Lauritzen, C., Reuter, H. D., Repges, R., Bohnert, K.-J., and Schmidt, U. (1997). Treatment of premenstrual tension syndrome with Vitex agnus castus. Controlled, double-blind study versus pyridoxin. Phytomedicine 4, 183-189.
Lehmann-Willenbrock, E., and Riedel, H. H. (1988). [Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa]. Zentralblatt fur Gynakologie 110, 611-618.
Levi, F., Pasche, C., Lucchini, F., and La Vecchia, C. (2001). Dietary intake of selected micronutrients and breast-cancer risk. International Journal of Cancer 91, 260-263.
Liske, E., Hanggi, W., Henneicke-von Zepelin, H. H., Boblitz, N., Wustenberg, P., and Rahlfs, V. W. (2002). Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 11, 163-174.
Loch, E. G., Selle, H., and Boblitz, N. (2000). Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gend Based Med 9, 315-320.
Lopez-Saez, J. B., Senra-Varela, A., and Pousa-Estevez, L. (2003). Selenium in breast cancer. Oncology 64, 227-231.
Mahady, G. B., Parrot, J., Lee, C., Yun, G. S., and Dan, A. (2003). Botanical dietary supplement use in peri- and postmenopausal women. Menopause 10, 65-72.
Maskarinec, G., Williams, A. E., and Carlin, L. (2003). Mammographic densities in a one-year isoflavone intervention. European Journal of Cancer Prevention 12, 165-169.
McMichael-Phillips, D. F., Harding, C., Morton, M., Roberts, S. A., Howell, A., Potten, C. S., and Bundred, N. J. (1998). Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. American Journal of Clinical Nutrition 68(suppl), 1431S-1436S.
Milewicz, A., Gejdel, E., Sworen, H., Sienkiewicz, K., Jedrzejak, J., Teucher, T., and Schmitz, H. (1993). [Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study]. Arzneimittel-Forschung 43, 752-756.
Moorman, P. G., Ricciuti, M. F., Millikan, R. C., and Newman, B. (2001). Vitamin supplement use and breast cancer in a North Carolina population. Public Health Nutr 4, 821-827.
Murkies, A. L., Lombard, C., Strauss, B. J., Wilcox, G., Burger, H. G., and Morton, M. S. (1995). Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 21, 189-195.
Nagata, C., Takatsuka, N., Kawakami, N., and Shimizu, H. (2001). Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. American Journal of Epidemiology 153, 790-793.
Newman, V., Rock, C. L., Faerber, S., Flatt, S. W., Wright, F. A., and Pierce, J. P. (1998). Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. Journal of the American Dietetic Association 98, 285-292.
Nikodem, V. C., Danziger, D., Gebka, N., Gulmezoglu, A. M., and Hofmeyr, G. J. (1993). Do cabbage leaves prevent breast engorgement? A randomized, controlled study. Birth 20, 61-64.
Penotti, M., Fabio, E., Modena, A. B., Rinaldi, M., Omodei, U., and Vigano, P. (2003). Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertility and Sterility 79, 1112-1117.
Petrakis, N. L., Barnes, S., King, E. B., Lowenstein, J., Wiencke, J., Lee, M. M., Miike, R., Kirk, M., and Coward, L. (1996). Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomark Prev 5, 785-794.
Pittler, M. H., and Ernst, E. (2003). Kava extract for treating anxiety. Cochrane Database Syst Rev, CD003383.
Puolakka, J., Makarainen, L., Viinikka, L., and Ylikorkala, O. (1985). Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. Journal of Reproductive Medicine 30, 149-153.
Quella, S. K., Loprinzi, C. L., Barton, D. L., Knost, J. A., Sloan, J. A., LaVasseur, B. I., Swan, D., Krupp, K. R., Miller, K. D., and Novotny, P. J. (2000). Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. Journal of Clinical Oncology 18, 1068-1074.
Riboli, E., and Norat, T. (2003). Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. American Journal of Clinical Nutrition 78, 559S-569S.
Roberts, K. L. (1995). A comparison of chilled cabbage leaves and chilled gelpaks in reducing breast engorgement. Journal of Human Lactation 11, 17-20.
Roberts, K. L., Reiter, M., and Schuster, D. (1995). A comparison of chilled and room temperature cabbage leaves in treating breast engorgement. Journal of Human Lactation 11, 191-194.
Roberts, K. L., Reiter, M., and Schuster, D. (1998). Effects of cabbage leaf extract on breast engorgement. Journal of Human Lactation 14, 231-236.
Ronco, A. L., De Stefani, E., and Dattoli, R. (2002). Dairy foods and risk of breast cancer: a case-control study in Montevideo, Uruguay. European Journal of Cancer Prevention 11, 457-463.
Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A., Howard, B. V., Johnson, K. C., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333.
Sato, R., Helzlsouer, K. J., Alberg, A. J., Hoffman, S. C., Norkus, E. P., and Comstock, G. W. (2002). Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 11, 451-457.
Scambia, G., Mango, D., Signorile, P. G., Anselmi Angeli, R. A., Palena, C., Gallo, D., Bombardelli, E., Morazzoni, P., Riva, A., and Mancuso, S. (2000). Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 7, 105-111.
Schellenberg, R. (2001). Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 322, 134-137.
Setchell, K. D., Brown, N. M., Desai, P., Zimmer-Nechemias, L., Wolfe, B. E., Brashear, W. T., Kirschner, A. S., Cassidy, A., and Heubi, J. E. (2001). Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. Journal of Nutrition 131, 1362S-1375S.
Shannon, J., Cook, L. S., and Stanford, J. L. (2003). Dietary intake and risk of postmenopausal breast cancer (United States). Cancer Causes and Control 14, 19-27.
Smith-Warner, S. A., Spiegelman, D., Yaun, S. S., Adami, H. O., Beeson, W. L., van den Brandt, P. A., Folsom, A. R., Fraser, G. E., Freudenheim, J. L., Goldbohm, R. A., et al. (2001). Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA 285, 769-776.
St Germain, A., Peterson, C. T., Robinson, J. G., and Alekel, D. L. (2001). Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 8, 17-26.
Standish, L. J., Greene, K., Greenlee, H., Kim, J. G., and Grosshans, C. (2002). Complementary and alternative medical treatment of breast cancer: a survey of licensed North American naturopathic physicians. Alternative Therapies in Health and Medicine 8, 68-70; 72-65.
Steiner, G. G. (2000). The correlation between cancer incidence and kava consumption. Hawaii Medical Journal 59, 420-422.
Stickel, F., Baumuller, H. M., Seitz, K., Vasilakis, D., Seitz, G., Seitz, H. K., and Schuppan, D. (2003). Hepatitis induced by Kava (Piper methysticum rhizoma). Journal of Hepatology 39, 62-67.
Tamborini, A., and Taurelle, R. (1993). [Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome]. Revue Francaise de Gynecologie et d Obstetrique 88, 447-457.
Tanaka, T. (2003). A novel anti-dysmenorrhea therapy with cyclic administration of two Japanese herbal medicines. Clinical and Experimental Obstetrics and Gynecology 30, 95-98.
Teschke, R., Gaus, W., and Loew, D. (2003). Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine 10, 440-446.
Tice, J. A., Ettinger, B., Ensrud, K., Wallace, R., Blackwell, T., and Cummings, S. R. (2003). Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 290, 207-214.
Trentham-Dietz, A., Newcomb, P. A., Storer, B. E., and Remington, P. L. (2000). Risk factors for carcinoma in situ of the breast. Cancer Epidemiology, Biomarkers and Prevention 9, 697-703.
Upmalis, D. H., Lobo, R., Bradley, L., Warren, M., Cone, F. L., and Lamia, C. A. (2000). Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 7, 236-242.
Vachon, C. M., Kushi, L. H., Cerhan, J. R., Kuni, C. C., and Sellers, T. A. (2000). Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiology, Biomarkers and Prevention 9, 151-160.
van de Weijer, P. H., and Barentsen, R. (2002). Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 42, 187-193.
van Gorkom, B. A., Karrenbeld, A., van Der Sluis, T., Koudstaal, J., de Vries, E. G., and Kleibeuker, J. H. (2000). Influence of a highly purified senna extract on colonic epithelium. Digestion 61, 113-120.
Van Patten, C. L., Olivotto, I. A., Chambers, G. K., Gelmon, K. A., Hislop, T. G., Templeton, E., Wattie, A., and Prior, J. C. (2002). Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. Journal of Clinical Oncology 20, 1449-1455.
Warnecke, G. (1991). [Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490]. Fortschritte der Medizin 109, 119-122.
Washburn, S., Burke, G. L., Morgan, T., and Anthony, M. (1999). Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6, 7-13.
Wiklund, I. K., Mattsson, L. A., Lindgren, R., and Limoni, C. (1999). Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. International Journal of Clinical Pharmacology Research 19, 89-99.
Wilson, M. L., and Murphy, P. A. (2001). Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev, CD002124.
Wu, A. H., Wan, P., Hankin, J., Tseng, C. C., Yu, M. C., and Pike, M. C. (2002). Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23, 1491-1496.
Wuttke, W., Jarry, H., Christoffel, V., Spengler, B., and Seidlova-Wuttke, D. (2003a). Chaste tree (Vitex agnus-castus)--pharmacology and clinical indications. Phytomedicine 10, 348-357.
Wuttke, W., Seidlova-Wuttke, D., and Gorkow, C. (2003b). The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 44, S67-77.
Yamamoto, S., Sobue, T., Kobayashi, M., Sasaki, S., and Tsugane, S. (2003). Soy, isoflavones, and breast cancer risk in Japan. Journal of the National Cancer Institute 95, 906-913.
Yu, S. M., Ghandour, R. M., and Huang, Z. J. (2004). Herbal supplement use among US women, 2000. J Am Med Womens Assoc 59, 17-24.
Yun, T. K., and Choi, S. Y. (1995). Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiology, Biomarkers and Prevention 4, 401-408.
Zhang, S., Hunter, D. J., Hankinson, S. E., Giovannucci, E. L., Rosner, B. A., Colditz, G. A., Speizer, F. E., and Willett, W. C. (1999). A prospective study of folate intake and the risk of breast cancer. JAMA 281, 1632-1637.
Zhang, S. M., Willett, W. C., Selhub, J., Hunter, D. J., Giovannucci, E. L., Holmes, M. D., Colditz, G. A., and Hankinson, S. E. (2003). Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. Journal of the National Cancer Institute 95, 373-380.
Borrelli, F., Izzo, A. A., and Ernst, E. (2003). Pharmacological effects of Cimicifuga racemosa. Life Sciences 73, 1215-1229.
Coldham, N. G., and Sauer, M. J. (2001). Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food and Chemical Toxicology 39, 1211-1224.
el-Ela, S. H., Prasse, K. W., Carroll, R., and Bunce, O. R. (1987). Effects of dietary primrose oil on mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene. Lipids 22, 1041-1044.
Mereto, E., Ghia, M., and Brambilla, G. (1996). Evaluation of the potential carcinogenic activity of Senna and Cascara glycosides for the rat colon. Cancer Letters 101, 79-83.
Nagasawa, H., Onoyama, T., Suzuki, M., Hibino, A., Segawa, T., and Inatomi, H. (1990). Effects of motherwort (Leonurus sibiricus L) on preneoplastic and neoplastic mammary gland growth in multiparous GR/A mice. Anticancer Research 10, 1019-1023.
Nagasawa, H., Inatomi, H., Suzuki, M., and Mori, T. (1992). Further study on the effects of motherwort (Leonurus sibiricus L) on preneoplastic and neoplastic mammary gland growth in multiparous GR/A mice. Anticancer Research 12, 141-143.
Paolini, M., Barillari, J., Broccoli, M., Pozzetti, L., Perocco, P., and Cantelli-Forti, G. (1999). Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolizing enzymes. Cancer Letters 145, 35-42.
Pritchard, G. A., Jones, D. L., and Mansel, R. E. (1989). Lipids in breast carcinogenesis. British Journal of Surgery 76, 1069-1073.
Rowlands, J. C., He, L., Hakkak, R., Ronis, M. J., and Badger, T. M. (2001). Soy and whey proteins downregulate DMBA-induced liver and mammary gland CYP1 expression in female rats. Journal of Nutrition 131, 3281-3287.
Salomi, N. J., Nair, S. C., Jayawardhanan, K. K., Varghese, C. D., and Panikkar, K. R. (1992). Antitumour principles from Nigella sativa seeds. Cancer Letters 63, 41-46.
Molecular and Cellular Studies
Amato, P., Christophe, S., and Mellon, P. L. (2002). Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 9, 145-150.
Bodinet, C., and Freudenstein, J. (2002). Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Research and Treatment 76, 1-10.
Boue, S. M., Wiese, T. E., Nehls, S., Burow, M. E., Elliott, S., Carter-Wientjes, C. H., Shih, B. Y., McLachlan, J. A., and Cleveland, T. E. (2003). Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. Journal of Agricultural and Food Chemistry 51, 2193-2199.
Chan, R. Y., Chen, W. F., Dong, A., Guo, D., and Wong, M. S. (2002). Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. Journal of Clinical Endocrinology and Metabolism 87, 3691-3695.
Dixon-Shanies, D., and Shaikh, N. (1999). Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncology Reports 6, 1383-1387.
Dragland, S., Senoo, H., Wake, K., Holte, K., and Blomhoff, R. (2003). Several culinary and medicinal herbs are important sources of dietary antioxidants. Journal of Nutrition 133, 1286-1290.
Duda, R. B., Zhong, Y., Navas, V., Li, M. Z., Toy, B. R., and Alavarez, J. G. (1999). American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. Journal of Surgical Oncology 72, 230-239.
Grube, B. J., Eng, E. T., Kao, Y. C., Kwon, A., and Chen, S. (2001). White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. Journal of Nutrition 131, 3288-3293.
Hecht, S. S. (1999). Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. Journal of Nutrition 129, 768S-774S.
Henderson, M. C., Miranda, C. L., Stevens, J. F., Deinzer, M. L., and Buhler, D. R. (2000). In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 30, 235-251.
Hsiang, C. Y., Lai, I. L., Chao, D. C., and Ho, T. Y. (2002). Differential regulation of activator protein 1 activity by glycyrrhizin. Life Sciences 70, 1643-1656.
Huang, C., Huang, Y., Li, J., Hu, W., Aziz, R., Tang, M. S., Sun, N., Cassady, J., and Stoner, G. D. (2002). Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts. Cancer Research 62, 6857-6863.
Jarry, H., Spengler, B., Porzel, A., Schmidt, J., Wuttke, W., and Christoffel, V. (2003). Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones. Planta Medica 69, 945-947.
Lee, Y., Jin, Y., Lim, W., Ji, S., Choi, S., Jang, S., and Lee, S. (2003a). A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. Journal of Steroid Biochemistry and Molecular Biology 84, 463-468.
Lee, Y. J., Jin, Y. R., Lim, W. C., Park, W. K., Cho, J. Y., Jang, S., and Lee, S. K. (2003b). Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells. Archives of Pharmacological Research 26, 58-63.
Liu, J., Burdette, J. E., Xu, H., Gu, C., van Breemen, R. B., Bhat, K. P., Booth, N., Constantinou, A. I., Pezzuto, J. M., Fong, H. H., et al. (2001). Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. Journal of Agricultural and Food Chemistry 49, 2472-2479.
Liu, M., Li, X. Q., Weber, C., Lee, C. Y., Brown, J., and Liu, R. H. (2002). Antioxidant and antiproliferative activities of raspberries. Journal of Agricultural and Food Chemistry 50, 2926-2930.
Maggiolini, M., Statti, G., Vivacqua, A., Gabriele, S., Rago, V., Loizzo, M., Menichini, F., and Amdo, S. (2002). Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 82, 315-322.
Miranda, C. L., Stevens, J. F., Helmrich, A., Henderson, M. C., Rodriguez, R. J., Yang, Y. H., Deinzer, M. L., Barnes, D. W., and Buhler, D. R. (1999). Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food and Chemical Toxicology 37, 271-285.
Nerurkar, P. V., Dragull, K., and Tang, C. S. (2004). In Vitro Toxicity of Kava Alkaloid, Pipermethystine, in HepG2 Cells as Compared to Kavalactones. Toxicological Sciences 21, 21.
Oh, M., Choi, Y. H., Choi, S., Chung, H., Kim, K., Kim, S. I., Kim, D. K., and Kim, N. D. (1999). Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. International Journal of Oncology 14, 869-875.
Rafi, M. M., Rosen, R. T., Vassil, A., Ho, C. T., Zhang, H., Ghai, G., Lambert, G., and DiPaola, R. S. (2000). Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Research 20, 2653-2658.
Rafi, M. M., Vastano, B. C., Zhu, N., Ho, C. T., Ghai, G., Rosen, R. T., Gallo, M. A., and DiPaola, R. S. (2002). Novel polyphenol molecule isolated from licorice root (Glycrrhiza glabra) induces apoptosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines. Journal of Agricultural and Food Chemistry 50, 677-684.
Rong, H., Boterberg, T., Maubach, J., Stove, C., Depypere, H., Van Slambrouck, S., Serreyn, R., De Keukeleire, D., Mareel, M., and Bracke, M. (2001). 8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells. European Journal of Cell Biology 80, 580-585.
Sicilia, T., Niemeyer, H. B., Honig, D. M., and Metzler, M. (2003). Identification and stereochemical characterization of lignans in flaxseed and pumpkin seeds. Journal of Agricultural and Food Chemistry 51, 1181-1188.
Sierens, J., Hartley, J. A., Campbell, M. J., Leathem, A. J., and Woodside, J. V. (2001). Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay. Mutation Research 485, 169-176.
Stoica, A., Saceda, M., Fakhro, A., Solomon, H. B., Fenster, B. D., and Martin, M. B. (1999). Regulation of estrogen receptor-alpha gene expression by 1, 25-dihydroxyvitamin D in MCF-7 cells. Journal of Cellular Biochemistry 75, 640-651.
Tamir, S., Eizenberg, M., Somjen, D., Stern, N., Shelach, R., Kaye, A., and Vaya, J. (2000). Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Research 60, 5704-5709.
Weitsman, G. E., Ravid, A., Liberman, U. A., and Koren, R. (2003). Vitamin D enhances caspase-dependent and -independent TNFalpha-induced breast cancer cell death: The role of reactive oxygen species and mitochondria. International Journal of Cancer 106, 178-186.
Yanase, T., Mu, Y. M., Nishi, Y., Goto, K., Nomura, M., Okabe, T., Takayanagi, R., and Nawata, H. (2001). Regulation of aromatase by nuclear receptors. Journal of Steroid Biochemistry and Molecular Biology 79, 187-192.
Zava, D. T., Dollbaum, C. M., and Blen, M. (1998). Estrogen and progestin bioactivity of foods, herbs, and spices. Proceedings of the Society for Experimental Biology and Medicine 217, 369-378.
Zierau, O., Bodinet, C., Kolba, S., Wulf, M., and Vollmer, G. (2002). Antiestrogenic activities of Cimicifuga racemosa extracts. Journal of Steroid Biochemistry and Molecular Biology 80, 125-130.
Prepared by Barbour Warren, Ph.D., Research Associate., BCERF.
We will make every effort to update this bibliography. If you have comments on this bibliography, or have a suggestion of a reference you would like us to review for inclusion in the bibliography, please send this information via email to: breastcancer@cornell.edu
Program on Breast Cancer and Environmental Risk Factors
Cornell University, College of Veterinary Medicine
Vet Box 31, Ithaca, NY 14853-6401
We comply with the HONcode standard for
trustworthy health information: Verify here.